These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21332389)

  • 21. RKIP downregulation induces the HBx-mediated Raf-1 mitochondrial translocation.
    Kim SY; Park SG; Jung H; Chi SW; Yu DY; Lee SC; Bae KH
    J Microbiol Biotechnol; 2011 May; 21(5):525-8. PubMed ID: 21617351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma].
    Wang Y; Yang J; Gao Y; Zhao XL; Li HZ; Yao Z
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):522-8. PubMed ID: 19957553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. u-PA and c-MET mRNA expression is co-ordinately enhanced while hepatocyte growth factor mRNA is down-regulated in human hepatocellular carcinoma.
    Tavian D; De Petro G; Benetti A; Portolani N; Giulini SM; Barlati S
    Int J Cancer; 2000 Sep; 87(5):644-9. PubMed ID: 10925356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis B virus protein up-regulated HLJ1 expression via the transcription factor YY1 in human hepatocarcinoma cells.
    Zhang L; Cai X; Chen K; Wang Z; Wang L; Ren M; Huang A; Tang H
    Virus Res; 2011 Apr; 157(1):76-81. PubMed ID: 21345358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual roles of nitric oxide in the regulation of tumor cell response and resistance to photodynamic therapy.
    Rapozzi V; Della Pietra E; Bonavida B
    Redox Biol; 2015 Dec; 6():311-317. PubMed ID: 26319434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of RKIP, STAT3 and cyclin D1 expression in pathogenesis of gastric cancer.
    Zhang XM; Zhou C; Gu H; Yan L; Zhang GY
    Int J Clin Exp Pathol; 2014; 7(9):5902-8. PubMed ID: 25337233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of Yin Yang 1 in bone marrow-derived human multiple myeloma and its clinical significance.
    Huerta-Yepez S; Liu H; Baritaki S; Del Lourdes Cebrera-Muñoz M; Rivera-Pazos C; Maldonado-Valenzuela A; Valencia-Hipolito A; Vega MI; Chen H; Berenson JR; Bonavida B
    Int J Oncol; 2014 Sep; 45(3):1184-92. PubMed ID: 24970600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of YY1 protein expression and mRNA levels by bioinformatics analysis in human cancers: a therapeutic target.
    Bonavida B; Kaufhold S
    Pharmacol Ther; 2015 Jun; 150():149-68. PubMed ID: 25619146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcription factor YY1 expression in human gastrointestinal cancer cells.
    Chinnappan D; Xiao D; Ratnasari A; Andry C; King TC; Weber HC
    Int J Oncol; 2009 May; 34(5):1417-23. PubMed ID: 19360355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo expression patterns of survivin and its splicing variants in chronic liver disease and hepatocellular carcinoma.
    Takashima H; Nakajima T; Moriguchi M; Sekoguchi S; Nishikawa T; Watanabe T; Katagishi T; Kimura H; Minami M; Itoh Y; Kagawa K; Okanoue T
    Liver Int; 2005 Feb; 25(1):77-84. PubMed ID: 15698402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of RKIP and its cross-talk with several regulatory gene products in multiple myeloma.
    Shvartsur A; Givechian KB; Garban H; Bonavida B
    J Exp Clin Cancer Res; 2017 May; 36(1):62. PubMed ID: 28476134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of c-myc mRNA in hepatocellular carcinomas, noncancerous livers, and normal livers.
    Ikeguchi M; Hirooka Y
    Pathobiology; 2004; 71(5):281-6. PubMed ID: 15459488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased immunoexpression of survivin could be a potential marker in human non-alcoholic fatty liver disease progression?
    Stefano JT; de Oliveira CP; Corrêa-Giannella ML; Soares IC; Kubrusly MS; Bellodi-Privato M; de Mello ES; de Lima VM; Carrilho FJ; Alves VA
    Liver Int; 2011 Mar; 31(3):377-85. PubMed ID: 21108736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between expression of Smac and Survivin and apoptosis of primary hepatocellular carcinoma.
    Bao ST; Gui SQ; Lin MS
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):580-3. PubMed ID: 17085346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Twist1-YY1-p300 complex promotes the malignant progression of HCC through activation of miR-9 by forming phase-separated condensates at super-enhancers and relieved by metformin.
    Meng J; Han J; Wang X; Wu T; Zhang H; An H; Qin L; Sun Y; Zhong W; Yang C; Liu H; Sun T
    Pharmacol Res; 2023 Feb; 188():106661. PubMed ID: 36669583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients.
    Al-Mulla F; Hagan S; Behbehani AI; Bitar MS; George SS; Going JJ; García JJ; Scott L; Fyfe N; Murray GI; Kolch W
    J Clin Oncol; 2006 Dec; 24(36):5672-9. PubMed ID: 17179102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.
    Zhang N; Li X; Wu CW; Dong Y; Cai M; Mok MT; Wang H; Chen J; Ng SS; Chen M; Sung JJ; Yu J
    Oncogene; 2013 Oct; 32(42):5078-88. PubMed ID: 23208495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular analysis of PinX1 in human hepatocellular carcinoma.
    Oh BK; Chae KJ; Park C; Park YN
    Oncol Rep; 2004 Oct; 12(4):861-6. PubMed ID: 15375513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
    Nardone G; Romano M; Calabrò A; Pedone PV; de Sio I; Persico M; Budillon G; Bruni CB; Riccio A; Zarrilli R
    Hepatology; 1996 Jun; 23(6):1304-12. PubMed ID: 8675143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of the Transcription Factor Yin Yang 1 and Its Selectively Identified Target Survivin in High-Grade B-Cells Non-Hodgkin Lymphomas: Potential Diagnostic and Therapeutic Targets.
    Vivarelli S; Falzone L; Ligresti G; Candido S; Garozzo A; Magro GG; Bonavida B; Libra M
    Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.